Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 2017 Nov 10;60(12):1399–1402. doi: 10.1007/s11427-017-9189-3

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses

Lei-Ping Zeng 1, Xing-Yi Ge 1, Cheng Peng 1, Wanbo Tai 2, Shibo Jiang 2,3, Lanying Du 2,, Zheng-Li Shi 1,
PMCID: PMC7089274  PMID: 29134417

The content is available as a PDF (458.7 KB).

Electronic supplementary material

11427_2017_9189_MOESM1_ESM.pptx (1.6MB, pptx)

Supplementary material, approximately 1.61 MB.

Acknowledgements

This work was supported by the National Natural Science Foundation of China (81290341, 31621061 to Zheng-Li Shi), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDPB0301 to Zheng-Li Shi), National Institute of Allergy and Infectious Diseases of National Institutes of Health grant (R01AI110964 to Zheng-Li Shi), the National Key Research and Development Program of China (2016YFC1201000 to Shibo Jiang) and NIH grant (R01AI098775 to Shibo Jiang and Lanying Du).

Contributor Information

Lanying Du, Email: ldu@nybc.org.

Zheng-Li Shi, Email: zlshi@wh.iov.cn.

References

  1. He Y., Lu H., Siddiqui P., Zhou Y., Jiang S. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J Immunol. 2005;174:4908–4915. doi: 10.4049/jimmunol.174.8.4908. [DOI] [PubMed] [Google Scholar]
  2. Hu B., Ge X., Wang L.F., Shi Z. Bat origin of human coronaviruses. Virol J. 2015;12:221. doi: 10.1186/s12985-015-0422-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jiang S., He Y., Liu S. SARS vaccine development. Emerg Infect Dis. 2005;11:1016–1020. doi: 10.3201/1107.050219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454. doi: 10.1038/nature02145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Wong S.K., Li W., Moore M.J., Choe H., Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem. 2004;279:3197–3201. doi: 10.1074/jbc.C300520200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Zeng L.P., Gao Y.T., Ge X.Y., Zhang Q., Peng C., Yang X.L., Tan B., Chen J., Chmura A.A., Daszak P., Shi Z.L. Bat severe acute respiratory syndrome-like coronavirus WIV1 encodes an extra accessory protein, ORFX, involved in modulation of the host immune response. J Virol. 2016;90:6573–6582. doi: 10.1128/JVI.03079-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Zhou P., Han Z., Wang L.F., Shi Z. Identification of immunogenic determinants of the spike protein of SARS-like coronavirus. Virol Sin. 2013;28:92–96. doi: 10.1007/s12250-013-3292-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Zhu Z., Chakraborti S., He Y., Roberts A., Sheahan T., Xiao X., Hensley L.E., Prabakaran P., Rockx B., Sidorov I.A., Corti D., Vogel L., Feng Y., Kim J.O., Wang L.F., Baric R., Lanzavecchia A., Curtis K.M., Nabel G.J., Subbarao K., Jiang S., Dimitrov D.S. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci USA. 2007;104:12123–12128. doi: 10.1073/pnas.0701000104. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

11427_2017_9189_MOESM1_ESM.pptx (1.6MB, pptx)

Supplementary material, approximately 1.61 MB.


Articles from Science China. Life Sciences are provided here courtesy of Nature Publishing Group

RESOURCES